SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Sep-24 4:56 PM View: | Chromocell Therapeutics Corp (CHRO) | 12-Sep-24 | Purchase | 10,400 | $0.94 | $9,824.88 | 13% 81.17K to 91.56K | |
14-Feb-22 6:49 PM View: | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-22 | Grant | 43,006 | -- | -- | 46% 93.56K to 136.56K | |
14-Feb-22 6:49 PM View: | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-22 | Payment of Exercise | 6,300 | $17.63 | $111,069.00 | (5%) 136.56K to 130.26K | |
05-Apr-21 7:07 PM View: | Collegium Pharmaceutical, Inc (COLL) | 01-Apr-21 | Payment of Exercise | 3,119 | $23.38 | $72,922.20 | (3%) 96.68K to 93.56K | (< 1%) |
12-Feb-21 4:13 PM View: | Collegium Pharmaceutical, Inc (COLL) | 10-Feb-21 | Payment of Exercise | 2,300 | $25.95 | $59,685.00 | (2%) 98.98K to 96.68K | 3% |
21-Jan-21 4:32 PM View: | Collegium Pharmaceutical, Inc (COLL) | 19-Jan-21 | Grant | 39,147 | -- | -- | 65% 59.83K to 98.98K | |
03-Apr-20 4:16 PM View: | Collegium Pharmaceutical, Inc (COLL) | 01-Apr-20 | Payment of Exercise | 2,920 | $15.49 | $45,230.80 | (5%) 62.75K to 59.83K | (22%) |
07-Feb-20 4:11 PM View: | Collegium Pharmaceutical, Inc (COLL) | 05-Feb-20 | Grant | 20,250 | -- | -- | 48% 42.5K to 62.75K | |
02-Apr-19 4:15 PM View: | Collegium Pharmaceutical, Inc (COLL) | 01-Apr-19 | Grant | 42,500 | -- | -- | 100% 0 to 42.5K |